Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.34
-0.07 (-0.94%)
At close: Oct 6, 2025, 4:00 PM EDT
7.30
-0.04 (-0.54%)
After-hours: Oct 6, 2025, 7:57 PM EDT

Gyre Therapeutics Statistics

Total Valuation

GYRE has a market cap or net worth of $666.67 million. The enterprise value is $613.70 million.

Market Cap666.67M
Enterprise Value 613.70M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

GYRE has 90.83 million shares outstanding. The number of shares has increased by 33.83% in one year.

Current Share Class 90.83M
Shares Outstanding 90.83M
Shares Change (YoY) +33.83%
Shares Change (QoQ) +0.72%
Owned by Insiders (%) 7.00%
Owned by Institutions (%) 3.79%
Float 20.46M

Valuation Ratios

The trailing PE ratio is 432.35 and the forward PE ratio is 20.68.

PE Ratio 432.35
Forward PE 20.68
PS Ratio 6.22
Forward PS 9.04
PB Ratio 7.24
P/TBV Ratio 7.66
P/FCF Ratio n/a
P/OCF Ratio 719.17
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 147.35
EV / Sales 6.01
EV / EBITDA 53.54
EV / EBIT 65.70
EV / FCF n/a

Financial Position

The company has a current ratio of 5.40, with a Debt / Equity ratio of 0.01.

Current Ratio 5.40
Quick Ratio 4.68
Debt / Equity 0.01
Debt / EBITDA 0.11
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 7.84% and return on invested capital (ROIC) is 5.16%.

Return on Equity (ROE) 7.84%
Return on Assets (ROA) 4.27%
Return on Invested Capital (ROIC) 5.16%
Return on Capital Employed (ROCE) 6.88%
Revenue Per Employee $176,492
Profits Per Employee $7,193
Employee Count579
Asset Turnover 0.75
Inventory Turnover 0.58

Taxes

In the past 12 months, GYRE has paid $2.84 million in taxes.

Income Tax 2.84M
Effective Tax Rate 24.54%

Stock Price Statistics

The stock price has decreased by -45.51% in the last 52 weeks. The beta is 7.11, so GYRE's price volatility has been higher than the market average.

Beta (5Y) 7.11
52-Week Price Change -45.51%
50-Day Moving Average 7.59
200-Day Moving Average 9.16
Relative Strength Index (RSI) 45.42
Average Volume (20 Days) 95,891

Short Selling Information

The latest short interest is 1.62 million, so 1.78% of the outstanding shares have been sold short.

Short Interest 1.62M
Short Previous Month 1.74M
Short % of Shares Out 1.78%
Short % of Float 7.91%
Short Ratio (days to cover) 16.80

Income Statement

In the last 12 months, GYRE had revenue of $102.19 million and earned $4.17 million in profits. Earnings per share was $0.02.

Revenue102.19M
Gross Profit 98.01M
Operating Income 9.34M
Pretax Income 11.58M
Net Income 4.17M
EBITDA 11.46M
EBIT 9.34M
Earnings Per Share (EPS) $0.02
Full Income Statement

Balance Sheet

The company has $54.37 million in cash and $1.39 million in debt, giving a net cash position of $52.97 million or $0.58 per share.

Cash & Cash Equivalents 54.37M
Total Debt 1.39M
Net Cash 52.97M
Net Cash Per Share $0.58
Equity (Book Value) 129.44M
Book Value Per Share 1.01
Working Capital 74.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $927,000 and capital expenditures -$1.01 million, giving a free cash flow of -$79,000.

Operating Cash Flow 927,000
Capital Expenditures -1.01M
Free Cash Flow -79,000
FCF Per Share -$0.00
Full Cash Flow Statement

Margins

Gross margin is 95.91%, with operating and profit margins of 9.14% and 4.08%.

Gross Margin 95.91%
Operating Margin 9.14%
Pretax Margin 11.33%
Profit Margin 4.08%
EBITDA Margin 11.22%
EBIT Margin 9.14%
FCF Margin n/a

Dividends & Yields

GYRE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -33.83%
Shareholder Yield -33.83%
Earnings Yield 0.62%
FCF Yield -0.01%
Dividend Details

Analyst Forecast

The average price target for GYRE is $18.00, which is 145.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target $18.00
Price Target Difference 145.23%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GYRE has an Altman Z-Score of 26.98 and a Piotroski F-Score of 4.

Altman Z-Score 26.98
Piotroski F-Score 4